KDM6B and non-small cell lung carcinoma: In non-small cell lung cancer patients, KDM6B significantly decreases in the serum and may play a pro-apoptotic role via promoting the nuclear translocation of FOXO1 (Ma et al., 2015; Ge et al., 2019).